FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38502111000001108: Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-May 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1340471000001112 Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1340481000001114 Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Is a Ondansetron 4mg orodispersible tablets 10 tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has AMP Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Healthcare Pharma Ltd) 10 tablet 2 x 5 tablets Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start